Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) benefits many patients with acute myeloid leukemia (AML) in first remission. Hitherto, little attention has been given to the prognostic impact of pretransplantation minimal residual disease (MRD). PATIENTS AND METHODS: We retrospectively...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Walter, Roland B., Gooley, Ted A., Wood, Brent L., Milano, Filippo, Fang, Min, Sorror, Mohamed L., Estey, Elihu H., Salter, Alexander I., Lansverk, Emily, Chien, Jason W., Gopal, Ajay K., Appelbaum, Frederick R., Pagel, John M.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2011
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3083874/
https://ncbi.nlm.nih.gov/pubmed/21282535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.8121
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items